Zhejiang Ausun Pharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Zhejiang Ausun Pharmaceutical Co., Ltd. is publicly traded on SHH under the ticker 603229.SS.
Established in 2010 and headquartered in Linhai, China, Zhejiang Ausun Pharmaceutical Co., Ltd. specializes in the research, development, production, and sale of unique active pharmaceutical ingredients (APIs) and various intermediate compounds for drug synthesis. Its comprehensive portfolio includes fluorine-based compounds, prostaglandins, and anti-infectives, in addition to critical oncology therapeutics. The...
Can you invest in Zhejiang Ausun Pharmaceutical Co., Ltd.?
Yes. Zhejiang Ausun Pharmaceutical Co., Ltd. trades publicly on SHH as 603229.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Zhejiang Ausun Pharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.